Menopause and Business; the IoD

The Institute of Directors - Menopause is still a taboo in business - Medical Prime UK

The summer months are turning out to be very warm indeed, so I do hope that you have been able to enjoy the weather and be safe at the same time. It is always a pleasure to see patients at our clinic, and via secure video link, or to speak to you on the telephone, especially when traveling or weather disruptions make it safer to do so remotely.  As many of you are already aware, we are experiencing a high demand for appointments, so please book as early as you are able.

I am pleased to share that The Institute of Directors (IoD) recently interviewed me about my personal journey with respect to healthcare, and my thoughts about companies in regard to perimenopause and menopause. I hope you will enjoy the article ‘Menopause is still a taboo in business’, which you can access here: Menopause is still a taboo in business, Dr. Theodora Kalentzi

I am also excited that The IoD London Region has recently created a Glass Ceiling Special Interest Group whose focus is to level the gender playing field for women in business. It is open to all genders. I have been invited to join the leadership team with a remit for women’s healthcare, a topic very close to my heart.

I am sure that you have been watching the economic news lately and unfortunately inflation is having an effect on all of us, including the clinic. With this in mind fees will rise for bookings made from 1 September 2022. Thank you for your understanding.

Our patient community is growing stronger and I am very grateful to those patients who share their stories, which people find very helpful and informative. There is a new patient story video that is currently being edited so do keep an eye out for it on our ‘Patients’ Stories page.

Needless to say, we would love you to include your story, therefore please get in touch with us if you would like to share your menopause journey.

With our best wishes,

Dr Theodora Kalentzi

Medical Prime Newsletter – SUBSCRIBE HERE